FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4251305296> ?p ?o ?g. }

• W4251305296 endingPage "ii64" @default.
• W4251305296 startingPage "ii63" @default.
• W4251305296 abstract "Abstract OBJECTIVE To estimate the 6-month Progression Free Survival (PFS6) associated with everolimus for progressive/recurrent pLGGs and to determine if activated PI3K/Akt/mTOR pathway as measured by positive phosphorylated-ribosomal protein S6 (p-RPS6) status was associated with response. METHOD Patients 3–21 years of age with recurrent or progressive pLGG were enrolled. Everolimus was administered orally at 5 mg/m2 daily. Tissue availability for molecular analysis was mandatory. Immunohistochemistry (IHC) for p-RPS6 was performed centrally. An adaptive Simon two-stage design was employed based on p-RPS6 status. Based on results of the first stage, enrollment in the second stage was either limited to pathway activated patients or open to all subjects. RESULTS From December 2012 to July 2019 a total of 65 subjects enrolled [median age 9 years (range 3–19); 43% female]. As of December 15, 2019 median number of treatment cycle is 8 (range 1–24); 7 patients remain on treatment. Toxicity profile is similar to published reports with rash and elevated lipid profiles as most common adverse events. PFS6 for the entire cohort is 63%; PFS6 is 64% for the activated and 61% for the non-activated patients. Central imaging review (n=52) revealed 1 partial response, 1 complete response, 33 stable disease, and 17 progressive disease at the end of study treatment. Initial molecular analysis identified BRAF alterations in 35/65 patients. CONCLUSION Everolimus is well tolerated and active in a subset of pLGGs. Ongoing analyses will assess predictive biomarkers of response and will be reported at the meeting." @default.
• W4251305296 created "2022-05-12" @default.
• W4251305296 creator A5004957233 @default.
• W4251305296 creator A5014547301 @default.
• W4251305296 creator A5031474146 @default.
• W4251305296 creator A5041913264 @default.
• W4251305296 creator A5045026723 @default.
• W4251305296 creator A5046437474 @default.
• W4251305296 creator A5047528677 @default.
• W4251305296 creator A5069511167 @default.
• W4251305296 creator A5078263289 @default.
• W4251305296 creator A5079323221 @default.
• W4251305296 creator A5084156179 @default.
• W4251305296 creator A5085032736 @default.
• W4251305296 creator A5088462429 @default.
• W4251305296 creator A5089347690 @default.
• W4251305296 creator A5090327960 @default.
• W4251305296 date "2020-11-01" @default.
• W4251305296 modified "2023-09-25" @default.
• W4251305296 title "DDRE-12. PNOC001 (NCT01734512): A PHASE II STUDY OF EVEROLIMUS FOR RECURRENT OR PROGRESSIVE PEDIATRIC LOW-GRADE GLIOMAS (pLGG)" @default.
• W4251305296 doi "https://doi.org/10.1093/neuonc/noaa215.257" @default.
• W4251305296 hasPublicationYear "2020" @default.
• W4251305296 type Work @default.
• W4251305296 citedByCount "1" @default.
• W4251305296 countsByYear W42513052962023 @default.
• W4251305296 crossrefType "journal-article" @default.
• W4251305296 hasAuthorship W4251305296A5004957233 @default.
• W4251305296 hasAuthorship W4251305296A5014547301 @default.
• W4251305296 hasAuthorship W4251305296A5031474146 @default.
• W4251305296 hasAuthorship W4251305296A5041913264 @default.
• W4251305296 hasAuthorship W4251305296A5045026723 @default.
• W4251305296 hasAuthorship W4251305296A5046437474 @default.
• W4251305296 hasAuthorship W4251305296A5047528677 @default.
• W4251305296 hasAuthorship W4251305296A5069511167 @default.
• W4251305296 hasAuthorship W4251305296A5078263289 @default.
• W4251305296 hasAuthorship W4251305296A5079323221 @default.
• W4251305296 hasAuthorship W4251305296A5084156179 @default.
• W4251305296 hasAuthorship W4251305296A5085032736 @default.
• W4251305296 hasAuthorship W4251305296A5088462429 @default.
• W4251305296 hasAuthorship W4251305296A5089347690 @default.
• W4251305296 hasAuthorship W4251305296A5090327960 @default.
• W4251305296 hasBestOaLocation W42513052961 @default.
• W4251305296 hasConcept C104202773 @default.
• W4251305296 hasConcept C126322002 @default.
• W4251305296 hasConcept C143998085 @default.
• W4251305296 hasConcept C146357865 @default.
• W4251305296 hasConcept C151730666 @default.
• W4251305296 hasConcept C190283241 @default.
• W4251305296 hasConcept C197934379 @default.
• W4251305296 hasConcept C204232928 @default.
• W4251305296 hasConcept C2778570526 @default.
• W4251305296 hasConcept C2778822529 @default.
• W4251305296 hasConcept C2779134260 @default.
• W4251305296 hasConcept C2779699572 @default.
• W4251305296 hasConcept C2780926556 @default.
• W4251305296 hasConcept C55493867 @default.
• W4251305296 hasConcept C71924100 @default.
• W4251305296 hasConcept C72563966 @default.
• W4251305296 hasConcept C86554907 @default.
• W4251305296 hasConcept C86803240 @default.
• W4251305296 hasConcept C90924648 @default.
• W4251305296 hasConceptScore W4251305296C104202773 @default.
• W4251305296 hasConceptScore W4251305296C126322002 @default.
• W4251305296 hasConceptScore W4251305296C143998085 @default.
• W4251305296 hasConceptScore W4251305296C146357865 @default.
• W4251305296 hasConceptScore W4251305296C151730666 @default.
• W4251305296 hasConceptScore W4251305296C190283241 @default.
• W4251305296 hasConceptScore W4251305296C197934379 @default.
• W4251305296 hasConceptScore W4251305296C204232928 @default.
• W4251305296 hasConceptScore W4251305296C2778570526 @default.
• W4251305296 hasConceptScore W4251305296C2778822529 @default.
• W4251305296 hasConceptScore W4251305296C2779134260 @default.
• W4251305296 hasConceptScore W4251305296C2779699572 @default.
• W4251305296 hasConceptScore W4251305296C2780926556 @default.
• W4251305296 hasConceptScore W4251305296C55493867 @default.
• W4251305296 hasConceptScore W4251305296C71924100 @default.
• W4251305296 hasConceptScore W4251305296C72563966 @default.
• W4251305296 hasConceptScore W4251305296C86554907 @default.
• W4251305296 hasConceptScore W4251305296C86803240 @default.
• W4251305296 hasConceptScore W4251305296C90924648 @default.
• W4251305296 hasIssue "Supplement_2" @default.
• W4251305296 hasLocation W42513052961 @default.
• W4251305296 hasLocation W42513052962 @default.
• W4251305296 hasLocation W42513052963 @default.
• W4251305296 hasOpenAccess W4251305296 @default.
• W4251305296 hasPrimaryLocation W42513052961 @default.
• W4251305296 hasRelatedWork W10386318 @default.
• W4251305296 hasRelatedWork W12927781 @default.
• W4251305296 hasRelatedWork W14070955 @default.
• W4251305296 hasRelatedWork W14327771 @default.
• W4251305296 hasRelatedWork W15036479 @default.
• W4251305296 hasRelatedWork W16174524 @default.
• W4251305296 hasRelatedWork W17437393 @default.
• W4251305296 hasRelatedWork W21036432 @default.
• W4251305296 hasRelatedWork W7720014 @default.
• W4251305296 hasRelatedWork W8428010 @default.
• W4251305296 hasVolume "22" @default.
• W4251305296 isParatext "false" @default.

• next